Home » Stocks » CERT

Certara, Inc. (CERT)

Stock Price: $37.20 USD 0.86 (2.37%)
Updated Jan 19, 2021 4:00 PM EST - Market closed
After-hours: $37.00 -0.20 (-0.54%) Jan 19, 7:39 PM
Market Cap 5.74B
Revenue (ttm) 232.75M
Net Income (ttm) -6.79M
Shares Out 157.35M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE 238.10
Dividend n/a
Dividend Yield n/a
Trading Day January 19
Last Price $37.20
Previous Close $36.34
Change ($) 0.86
Change (%) 2.37%
Day's Open 36.67
Day's Range 36.70 - 38.59
Day's Volume 529,345
52-Week Range 32.37 - 40.18

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 1 month ago

STOCKHOLM, Dec. 17, 2020 /PRNewswire/ -- EQT is pleased to announce that on 10 December 2020, the EQT VII portfolio company Certara, Inc. ("Certara"), a global leader in biosimulation based on...

Business Wire - 1 month ago

PRINCETON, N.J.--(BUSINESS WIRE)--Certara today announced that it closed its upsized initial public offering of 33,413,250 shares of common stock at $23.00 per share.

The Motley Fool - 1 month ago

Hot initial public offerings aren't just for technology companies.

Other stocks mentioned: ABCL
Bloomberg Markets and Finance - 1 month ago

Drug Software Firm Certara Expands IPO to Raise $668 Million

Dec.11 -- Certara Inc., a maker of drug-development software, upsized its initial public offering and priced it above the marketed range to raise $668 million, adding to the red-hot week for U...

CNBC Television - 1 month ago

Certara CEO on strong IPO debut

CNBC's "Squawk Alley" team discusses Certara's IPO with CEO William Feehery.

Barrons - 1 month ago

Four companies increased the size of their deals.

Other stocks mentioned: ABCL
Business Wire - 1 month ago

PRINCETON, N.J.--(BUSINESS WIRE)--Certara today announced the pricing of its upsized initial public offering of 29,055,000 shares of its common stock at $23.00 per share.

InvestorPlace - 1 month ago

The list of upcoming IPOs is starting to perk up. Here's a look at some interesting deals, including a variety of tech operators.

Other stocks mentioned: ABNB, AI, DASH, PUBM
Seeking Alpha - 1 month ago

Certara has filed proposed terms for its $500 million U.S. IPO.

NASDAQ - 2 months ago

Certara, which provides biosimulation software and services used for drug development, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering. However, t...

SEC - 2 months ago

Certara, Inc. has filed to go public with an IPO on the NASDAQ.

About CERT

Certara provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empiric... [Read more...]

Industry
Biotechnology
IPO Date
Dec 11, 2020
CEO
William F. Feehery
Employees
841
Stock Exchange
NASDAQ
Ticker Symbol
CERT
Full Company Profile

Financial Performance

In 2019, Certara's revenue was $208.51 million, an increase of 27.36% compared to the previous year's $163.72 million. Losses were -$8.93 million, -73.16% less than in 2018.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for Certara stock is "Buy." The 12-month stock price forecast is 36.00, which is a decrease of -3.23% from the latest price.

Price Target
$36.00
(-3.23% downside)
Analyst Consensus: Buy